| Western blot (WB): | 1:500-2000 |
| Immunohistochemistry (IHC): | 1:50-400 |
| Immunofluorescence (IF): | 1:50-400 |
| (Boiling the paraffin sections in 10mM citrate buffer,pH6.0,or PH8.0 EDTA repair liquid for 20 mins is required for the staining of formalin/paraffin sections.) Optimal working dilutions must be determined by end user. | |

IF analysis using Anti-CAV1 antibody (M00179-1) detected in paraffin-embedded section of human lung cancer tissue. The tissue section were stained using the Fluoro488 Anti-Mouse IgG Secondary Antibody (green)(Catalog#BA1127) and counterstained with DAPI (blue).

IF analysis using Anti-CAV1 antibody (M00179-1) detected in paraffin-embedded section of human colon cancer tissue. The tissue section were stained using the Fluoro488 Anti-Mouse IgG Secondary Antibody (green)(Catalog#BA1127) and counterstained with DAPI (blue).

Western blot analysis of Caveolin-1/CAV1 using anti-Caveolin-1/CAV1 antibody (M00179-1). The sample well of each lane was loaded with 30 ug of sample under reducing conditions.
Lane 1: human Hela whole cell lysates,
Lane 2: human A549 whole cell lysates,
Lane 3: human placenta tissue lysates,
Lane 4: human U-87 whole cell lysates,
Lane 5: human PC-3 whole cell lysates,
Lane 6: human U2OS whole cell lysates.
After electrophoresis, proteins were transferred to a membrane. Then the membrane was incubated with mouse anti-Caveolin-1/CAV1 antigen affinity purified monoclonal antibody (M00179-1) at a dilution of 1:1000 and probed with a goat anti-mouse IgG-HRP secondary antibody (Catalog # BA1050). The signal is developed using ECL Plus Western Blotting Substrate (Catalog # AR1197). A specific band was detected for Caveolin-1/CAV1 at approximately 22 kDa. The expected band size for Caveolin-1/CAV1 is at 20 kDa.

IHC analysis of Caveolin-1/CAV1 using anti-Caveolin-1/CAV1 antibody (M00179-1).
Caveolin-1/CAV1 was detected in a paraffin-embedded section of human intestinal cancer tissue. Biotinylated goat anti-mouse IgG was used as secondary antibody. The tissue section was incubated with mouse anti-Caveolin-1/CAV1 Antibody (M00179-1) at a dilution of 1:200 and developed using Strepavidin-Biotin-Complex (SABC) (Catalog # SA1021) with DAB (Catalog # AR1027) as the chromogen.

IHC analysis of Caveolin-1/CAV1 using anti-Caveolin-1/CAV1 antibody (M00179-1).
Caveolin-1/CAV1 was detected in a paraffin-embedded section of human lung cancer tissue. Biotinylated goat anti-mouse IgG was used as secondary antibody. The tissue section was incubated with mouse anti-Caveolin-1/CAV1 Antibody (M00179-1) at a dilution of 1:200 and developed using Strepavidin-Biotin-Complex (SABC) (Catalog # SA1021) with DAB (Catalog # AR1027) as the chromogen.

IHC analysis of Caveolin-1/CAV1 using anti-Caveolin-1/CAV1 antibody (M00179-1).
Caveolin-1/CAV1 was detected in a paraffin-embedded section of human melanoma tissue. Biotinylated goat anti-mouse IgG was used as secondary antibody. The tissue section was incubated with mouse anti-Caveolin-1/CAV1 Antibody (M00179-1) at a dilution of 1:200 and developed using Strepavidin-Biotin-Complex (SABC) (Catalog # SA1021) with DAB (Catalog # AR1027) as the chromogen.

IHC analysis of Caveolin-1/CAV1 using anti-Caveolin-1/CAV1 antibody (M00179-1).
Caveolin-1/CAV1 was detected in a paraffin-embedded section of human intestine tissue. Biotinylated goat anti-mouse IgG was used as secondary antibody. The tissue section was incubated with mouse anti-Caveolin-1/CAV1 Antibody (M00179-1) at a dilution of 1:200 and developed using Strepavidin-Biotin-Complex (SABC) (Catalog # SA1021) with DAB (Catalog # AR1027) as the chromogen.

IHC analysis of Caveolin-1/CAV1 using anti-Caveolin-1/CAV1 antibody (M00179-1).
Caveolin-1/CAV1 was detected in a paraffin-embedded section of human placenta cancer tissue. Biotinylated goat anti-mouse IgG was used as secondary antibody. The tissue section was incubated with mouse anti-Caveolin-1/CAV1 Antibody (M00179-1) at a dilution of 1:200 and developed using Strepavidin-Biotin-Complex (SABC) (Catalog # SA1021) with DAB (Catalog # AR1027) as the chromogen.

IF analysis using Anti-CAV1 antibody (M00179-1) detected in paraffin-embedded section of human lung cancer tissue. The tissue section were stained using the Fluoro488 Anti-Mouse IgG Secondary Antibody (green)(Catalog#BA1127) and counterstained with DAPI (blue).

IF analysis using Anti-CAV1 antibody (M00179-1) detected in paraffin-embedded section of human colon cancer tissue. The tissue section were stained using the Fluoro488 Anti-Mouse IgG Secondary Antibody (green)(Catalog#BA1127) and counterstained with DAPI (blue).

Western blot analysis of Caveolin-1/CAV1 using anti-Caveolin-1/CAV1 antibody (M00179-1). The sample well of each lane was loaded with 30 ug of sample under reducing conditions.
Lane 1: human Hela whole cell lysates,
Lane 2: human A549 whole cell lysates,
Lane 3: human placenta tissue lysates,
Lane 4: human U-87 whole cell lysates,
Lane 5: human PC-3 whole cell lysates,
Lane 6: human U2OS whole cell lysates.
After electrophoresis, proteins were transferred to a membrane. Then the membrane was incubated with mouse anti-Caveolin-1/CAV1 antigen affinity purified monoclonal antibody (M00179-1) at a dilution of 1:1000 and probed with a goat anti-mouse IgG-HRP secondary antibody (Catalog # BA1050). The signal is developed using ECL Plus Western Blotting Substrate (Catalog # AR1197). A specific band was detected for Caveolin-1/CAV1 at approximately 22 kDa. The expected band size for Caveolin-1/CAV1 is at 20 kDa.

IHC analysis of Caveolin-1/CAV1 using anti-Caveolin-1/CAV1 antibody (M00179-1).
Caveolin-1/CAV1 was detected in a paraffin-embedded section of human intestinal cancer tissue. Biotinylated goat anti-mouse IgG was used as secondary antibody. The tissue section was incubated with mouse anti-Caveolin-1/CAV1 Antibody (M00179-1) at a dilution of 1:200 and developed using Strepavidin-Biotin-Complex (SABC) (Catalog # SA1021) with DAB (Catalog # AR1027) as the chromogen.

IHC analysis of Caveolin-1/CAV1 using anti-Caveolin-1/CAV1 antibody (M00179-1).
Caveolin-1/CAV1 was detected in a paraffin-embedded section of human lung cancer tissue. Biotinylated goat anti-mouse IgG was used as secondary antibody. The tissue section was incubated with mouse anti-Caveolin-1/CAV1 Antibody (M00179-1) at a dilution of 1:200 and developed using Strepavidin-Biotin-Complex (SABC) (Catalog # SA1021) with DAB (Catalog # AR1027) as the chromogen.

IHC analysis of Caveolin-1/CAV1 using anti-Caveolin-1/CAV1 antibody (M00179-1).
Caveolin-1/CAV1 was detected in a paraffin-embedded section of human melanoma tissue. Biotinylated goat anti-mouse IgG was used as secondary antibody. The tissue section was incubated with mouse anti-Caveolin-1/CAV1 Antibody (M00179-1) at a dilution of 1:200 and developed using Strepavidin-Biotin-Complex (SABC) (Catalog # SA1021) with DAB (Catalog # AR1027) as the chromogen.

IHC analysis of Caveolin-1/CAV1 using anti-Caveolin-1/CAV1 antibody (M00179-1).
Caveolin-1/CAV1 was detected in a paraffin-embedded section of human intestine tissue. Biotinylated goat anti-mouse IgG was used as secondary antibody. The tissue section was incubated with mouse anti-Caveolin-1/CAV1 Antibody (M00179-1) at a dilution of 1:200 and developed using Strepavidin-Biotin-Complex (SABC) (Catalog # SA1021) with DAB (Catalog # AR1027) as the chromogen.

IHC analysis of Caveolin-1/CAV1 using anti-Caveolin-1/CAV1 antibody (M00179-1).
Caveolin-1/CAV1 was detected in a paraffin-embedded section of human placenta cancer tissue. Biotinylated goat anti-mouse IgG was used as secondary antibody. The tissue section was incubated with mouse anti-Caveolin-1/CAV1 Antibody (M00179-1) at a dilution of 1:200 and developed using Strepavidin-Biotin-Complex (SABC) (Catalog # SA1021) with DAB (Catalog # AR1027) as the chromogen.







